These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22226772

  • 21. Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells.
    Wang X, Ikejima K, Kon K, Arai K, Aoyama T, Okumura K, Abe W, Sato N, Watanabe S.
    J Hepatol; 2011 Aug; 55(2):379-87. PubMed ID: 21168456
    [Abstract] [Full Text] [Related]

  • 22. Chemically modified liposomes carrying TRAIL target activated hepatic stellate cells and ameliorate hepatic fibrosis in vitro and in vivo.
    Li Q, Ding Y, Guo X, Luo S, Zhuang H, Zhou J, Xu N, Yan Z.
    J Cell Mol Med; 2019 Mar; 23(3):1951-1962. PubMed ID: 30592139
    [Abstract] [Full Text] [Related]

  • 23. Caffeine attenuates liver fibrosis via defective adhesion of hepatic stellate cells in cirrhotic model.
    Shim SG, Jun DW, Kim EK, Saeed WK, Lee KN, Lee HL, Lee OY, Choi HS, Yoon BC.
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1877-84. PubMed ID: 23808892
    [Abstract] [Full Text] [Related]

  • 24. Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
    Yoshiji H, Kuriyama S, Noguchi R, Yoshii J, Ikenaka Y, Yanase K, Namisaki T, Kitade M, Yamazaki M, Tsujinoue H, Fukui H.
    Liver Int; 2005 Feb; 25(1):153-61. PubMed ID: 15698413
    [Abstract] [Full Text] [Related]

  • 25. Preparation and evaluation of hepatic stellate cell selective, surface conjugated, peroxisome proliferator-activated receptor-gamma ligand loaded liposomes.
    Patel G, Kher G, Misra A.
    J Drug Target; 2012 Feb; 20(2):155-65. PubMed ID: 21913877
    [Abstract] [Full Text] [Related]

  • 26. Antifibrotic effects of tetrandrine on hepatic stellate cells and rats with liver fibrosis.
    Hsu YC, Chiu YT, Cheng CC, Wu CF, Lin YL, Huang YT.
    J Gastroenterol Hepatol; 2007 Jan; 22(1):99-111. PubMed ID: 17201889
    [Abstract] [Full Text] [Related]

  • 27. Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis.
    El-Mezayen NS, El-Hadidy WF, El-Refaie WM, Shalaby TI, Khattab MM, El-Khatib AS.
    J Control Release; 2017 Nov 28; 266():226-237. PubMed ID: 28965860
    [Abstract] [Full Text] [Related]

  • 28. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y, Ping J, Xu LM.
    Chin Med J (Engl); 2007 May 05; 120(9):794-801. PubMed ID: 17531121
    [Abstract] [Full Text] [Related]

  • 29. Local inhibition of liver fibrosis by specific delivery of a platelet-derived growth factor kinase inhibitor to hepatic stellate cells.
    Gonzalo T, Beljaars L, van de Bovenkamp M, Temming K, van Loenen AM, Reker-Smit C, Meijer DK, Lacombe M, Opdam F, Kéri G, Orfi L, Poelstra K, Kok RJ.
    J Pharmacol Exp Ther; 2007 Jun 05; 321(3):856-65. PubMed ID: 17369283
    [Abstract] [Full Text] [Related]

  • 30. Interferon gamma inhibits lipocyte activation and extracellular matrix mRNA expression during experimental liver injury: implications for treatment of hepatic fibrosis.
    Rockey DC, Chung JJ.
    J Investig Med; 1994 Dec 05; 42(4):660-70. PubMed ID: 8521029
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Octreotide modulates the effects on fibrosis of TNF-α, TGF-β and PDGF in activated rat hepatic stellate cells.
    Klironomos S, Notas G, Sfakianaki O, Kiagiadaki F, Xidakis C, Kouroumalis E.
    Regul Pept; 2014 Jan 10; 188():5-12. PubMed ID: 24291170
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
    Weng H, Mertens PR, Gressner AM, Dooley S.
    J Hepatol; 2007 Feb 10; 46(2):295-303. PubMed ID: 17125875
    [Abstract] [Full Text] [Related]

  • 36. New insights into the antifibrotic effects of sorafenib on hepatic stellate cells and liver fibrosis.
    Wang Y, Gao J, Zhang D, Zhang J, Ma J, Jiang H.
    J Hepatol; 2010 Jul 10; 53(1):132-44. PubMed ID: 20447716
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Disease-induced drug targeting using novel peptide-ligand albumins.
    Meijer DK, Beljaars L, Molema G, Poelstra K.
    J Control Release; 2001 May 14; 72(1-3):157-64. PubMed ID: 11389994
    [Abstract] [Full Text] [Related]

  • 39. Effects and mechanisms of extract from Paeonia lactiflora and Astragalus membranaceus on liver fibrosis induced by carbon tetrachloride in rats.
    Sun WY, Wei W, Wu L, Gui SY, Wang H.
    J Ethnopharmacol; 2007 Jul 25; 112(3):514-23. PubMed ID: 17574357
    [Abstract] [Full Text] [Related]

  • 40. RNA interference targeting the platelet-derived growth factor receptor beta subunit ameliorates experimental hepatic fibrosis in rats.
    Chen SW, Zhang XR, Wang CZ, Chen WZ, Xie WF, Chen YX.
    Liver Int; 2008 Dec 25; 28(10):1446-57. PubMed ID: 18466260
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.